Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The involvement of the RET variant G691S in medullary thyroid carcinoma enlightened by a meta-analysis study.

Lantieri F, Caroli F, Ceccherini I, Griseri P.

Int J Cancer. 2013 Jun 15;132(12):2808-19. doi: 10.1002/ijc.27967. Epub 2012 Dec 27.

2.

Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.

Machens A, Frank-Raue K, Lorenz K, Rondot S, Raue F, Dralle H.

Clin Endocrinol (Oxf). 2012 May;76(5):691-7. doi: 10.1111/j.1365-2265.2011.04293.x.

PMID:
22111543
3.

RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.

Elisei R, Cosci B, Romei C, Bottici V, Sculli M, Lari R, Barale R, Pacini F, Pinchera A.

J Clin Endocrinol Metab. 2004 Jul;89(7):3579-84.

PMID:
15240649
4.

[G691S, L769L and S836S ret proto-oncogene polymorphisms are not associated with higher risk to sporadic medullary thyroid carcinoma in Chilean patients].

Wohllk G N, Soto C E, Bravo A M, Becker C P.

Rev Med Chil. 2005 Apr;133(4):397-402. Epub 2005 Jun 8. Spanish.

5.

Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.

Figlioli G, Landi S, Romei C, Elisei R, Gemignani F.

Mutat Res. 2013 Jan-Mar;752(1):36-44. doi: 10.1016/j.mrrev.2012.09.002. Epub 2012 Oct 8. Review.

PMID:
23059849
6.

Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness.

Ceolin L, Siqueira DR, Ferreira CV, Romitti M, Maia SC, Leiria L, Crispim D, Ashton-Prolla P, Maia AL.

Eur J Endocrinol. 2012 May;166(5):847-54. doi: 10.1530/EJE-11-1060. Epub 2012 Feb 17. Erratum in: Eur J Endocrinol. 2012 Jun;166(6):1121. Prolla, Patrícia Ashton [corrected to Ashton-Prolla, Patrícia].

7.

The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.

Colombo C, Minna E, Rizzetti MG, Romeo P, Lecis D, Persani L, Mondellini P, Pierotti MA, Greco A, Fugazzola L, Borrello MG.

Orphanet J Rare Dis. 2015 Mar 1;10:25. doi: 10.1186/s13023-015-0231-z.

8.

Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.

Khan MS, Pandith AA, Iqbal M, Naykoo NA, Khan SH, Rather TA, Mudassar S.

J Cell Biochem. 2015 Aug;116(8):1712-8. doi: 10.1002/jcb.25130.

PMID:
25736215
9.

Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism.

Rotondi M, Ercolino T, Fonte R, Lagonigro MS, Leporati P, Villani L, La Manna L, Mannelli M, Chiovato L.

J Endocrinol Invest. 2009 Feb;32(2):115-8.

PMID:
19411807
10.

Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.

Borrello MG, Aiello A, Peissel B, Rizzetti MG, Mondellini P, Degl'Innocenti D, Catalano V, Gobbo M, Collini P, Bongarzone I, Pierotti MA, Greco A, Seregni E.

Endocr Relat Cancer. 2011 Jul 25;18(4):519-27. doi: 10.1530/ERC-10-0306. Print 2011 Aug.

11.

The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.

Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL.

Endocr Relat Cancer. 2010 Oct 5;17(4):953-63. doi: 10.1677/ERC-09-0312. Print 2010 Dec.

12.

Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?

Cardot-Bauters C, Leteurtre E, Leclerc L, Vantyghem MC, Do Cao C, Wemeau JL, d'Herbomez M, Carnaille B, Barbu V, Pinson S, Pigny P; Groupe d'Etude des Tumeurs Endocrines (GTE)..

Clin Endocrinol (Oxf). 2008 Sep;69(3):506-10. doi: 10.1111/j.1365-2265.2008.03230.x. Epub 2008 Mar 10.

PMID:
18331611
13.

RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series.

Fugazzola L, Muzza M, Mian C, Cordella D, Barollo S, Alberti L, Cirello V, Dazzi D, Girelli ME, Opocher G, Beck-Peccoz P, Persani L.

Clin Endocrinol (Oxf). 2008 Sep;69(3):418-25. doi: 10.1111/j.1365-2265.2008.03218.x. Epub 2008 Feb 11.

PMID:
18284634
14.

RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population.

Costa P, Domingues R, Sobrinho LG, Bugalho MJ.

Endocrine. 2005 Aug;27(3):239-43.

PMID:
16230779
15.

Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.

Gursoy A, Erdogan MF, Erdogan G.

J Endocrinol Invest. 2006 Nov;29(10):858-62.

PMID:
17185892
16.

Quantitative assessment of the association between L769L and S836S polymorphisms at RET gene and medullary thyroid carcinoma risk.

Zhang Y, Wang S, Chen X, Huang S, Li J.

Tumour Biol. 2014 Jul;35(7):6641-7. doi: 10.1007/s13277-014-1878-0. Epub 2014 Apr 4.

PMID:
24699996
17.

Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.

Cebrian A, Lesueur F, Martin S, Leyland J, Ahmed S, Luccarini C, Smith PL, Luben R, Whittaker J, Pharoah PD, Dunning AM, Ponder BA.

J Clin Endocrinol Metab. 2005 Nov;90(11):6268-74. Epub 2005 Aug 9.

PMID:
16091499
18.

RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.

Neocleous V, Skordis N, Portides G, Efstathiou E, Costi C, Ioannou N, Pantzaris M, Anastasiadou V, Deltas C, Phylactou LA.

J Endocrinol Invest. 2011 Nov;34(10):764-9. doi: 10.3275/7605. Epub 2011 Mar 21.

PMID:
21422799
19.

Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma.

Fernández RM, Peciña A, Antiñolo G, Navarro E, Borrego S.

Thyroid. 2006 Apr;16(4):411-7.

PMID:
16646689
20.

Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.

Sheikholeslami S, Zarif Yeganeh M, Hoghooghi Rad L, Golab Ghadaksaz H, Hedayati M.

Iran J Public Health. 2014 Feb;43(2):235-40.

Supplemental Content

Support Center